Sensus Healthcare (SRTS) EBITDA (2016 - 2025)

Sensus Healthcare has reported EBITDA for 10 years, with the latest figure at -$3.1 million in Q4 2025.

• On a quarterly basis, EBITDA fell 282.39% year-over-year to -$3.1 million in Q4 2025; TTM through Dec 2025 was -$10.3 million, a 227.39% decrease from a year earlier, with the FY2025 full-year figure at -$10.3 million, down 227.4% from the prior year.
• EBITDA was -$3.1 million for Q4 2025 at Sensus Healthcare, down from -$2.6 million in the prior quarter.
• The five-year high for EBITDA was $5.6 million in Q4 2023, with the low at -$3.1 million in Q4 2025.
• Average EBITDA over 5 years is $817650.0, with a median of $845000.0 recorded in 2021.
• The sharpest annual moves came in 2021 and 2025: EBITDA surged 1969.65% in 2021, then sank 282.39% in 2025.
• Over 5 years, EBITDA stood at $5.3 million in 2021, then declined by 21.56% to $4.2 million in 2022, then surged by 33.68% to $5.6 million in 2023, then sank by 69.05% to $1.7 million in 2024, then tumbled by 282.39% to -$3.1 million in 2025.
• The last three EBITDA figures came in at -$3.1 million (Q4 2025), -$2.6 million (Q3 2025), and -$1.9 million (Q2 2025), per Business Quant data.